Komori
General Meetings of Shareholders4549EIKEN CHEMICAL CO.,LTD.Pharmaceuticals

ISS Recommendation Report on the Proposals to Be Submitted to Our Annual General Meeting of Shareholders (For the Company’s Proposals and Against the Shareholder Proposals)

ISS recommended voting in favor of the company proposal to elect 10 directors and against the shareholder proposal to elect 2 directors.

Worth reading
68In focus
Scored from 3 of 4 sections
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Resolutions for the General Meeting of Shareholders

Annual (88th)
2026
Jun 23
Date and time(start time: Not disclosed)19 days from this disclosure to the meeting
Matters for resolution2 items (1 from the company, 1 from shareholders)
  1. Election of 10 directors

  2. Election of 2 directors

    Shareholder Proposal
Shareholder Proposal

The proponent is Not disclosed. For Proposal No. 2, Election of 2 Directors, ISS recommended voting against the proposal. The Company's board of directors also opposed it.

A shareholder proposal is a resolution submitted by a shareholder, rather than by the company.
Director nomineeNumber of candidates: 10 under the company proposal and 2 under the shareholder proposal. The numbers of new and outside candidates are Not disclosed.
Resolutions for the General Meeting of Shareholders
ItemDetails
Type of shareholders' meetingAnnual (88th)
Date and time23 June 2026 (start time: Not disclosed)
Matters for resolutionProposal No. 1: Election of 10 directors, Proposal No. 2: Election of 2 directors
Shareholder ProposalThe proponent is Not disclosed. For Proposal No. 2, Election of 2 Directors, ISS recommended voting against the proposal. The Company's board of directors also opposed it.
Director nomineeNumber of candidates: 10 under the company proposal and 2 under the shareholder proposal. The numbers of new and outside candidates are Not disclosed.
Items this document does not state (1)
Percentage voting in favor

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

ISS pointed out that the shareholder proponent appeared not to have adequately communicated its assertions to general shareholders. The Company cited concerns regarding the independence of the shareholder-proposed candidates, the risk that adequate management oversight would not be ensured, the risk that the interests of general shareholders would be harmed, and the view that the board proposed by the Company is optimal from the perspective of maximizing corporate and shareholder value as reasons for opposing the shareholder proposal.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
ISS Recommendation Report on the Proposals to Be Submitted to Our Annual General Meeting of Shareholders (For the Company’s Proposals and Against the Shareholder Proposals) | EIKEN CHEMICAL CO.,LTD. (4549) timely disclosure | Komori